Policy
-
Forward Look
Adequate RepresentationMedical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Policy Matters
Cancer Research: The Key to Tomorrow’s CuresThe AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.
by David A. Tuveson, MD, PhD
-
Facts and Stats
Fifty Years of Growing SurvivorshipMore people in the U.S. are alive after being diagnosed with cancer than ever before.
by Eric Fitzsimmons
-
From the Editor-in-Chief
Improving Clinical TrialsThe fast pace of drug discovery should be matched by modernized clinical trials for wider access.
by William G. Nelson, MD, PhD
-
Oncology Takes on CannabisPeople take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.
by Kate Yandell
-
Policy Matters
The FDA Takes Steps to Curb Tobacco UseThe federal agency wants to ban menthol-flavored cigarettes, ban all flavors of cigars, and limit nicotine content.
by Nicholas Warren, PhD
-
Preconceived Notions: Cancer, Fertility Coverage and the LawInsurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.
by Shelly Rosenfeld
-
Open Medical Records: Pros and ConsPatients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
-
Policy Matters
COVID-19 Vaccines Are the Key to Restoring Momentum Against CancerCancer screenings and clinical trials have been seriously disrupted by the pandemic.
by Nicholas Warren, PhD
-
Hope for Cancer Health EquityHealth care providers and communities are making strides toward ensuring equity in cancer treatment.
by Marci A. Landsmann
